UMediC Group Berhad's stock price has decreased recently, but its strong financials suggest long-term growth potential. ROE of 13% indicates profitability and efficient use of investors' money. The company's reinvestment strategy has led to impressive earnings growth and is expected to continue.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing